Resverlogix (STU:RFS) General and Admin. Expense: €1.72 Mil (TTM As of Mar. 2026)

Resverlogix STU:RFS 39 General and Admin. Expense is €1.72 Mil as of Mar. 2026. GuruFocus rates STU:RFS with a GF Score™ of 39/100. The stock has 4 warning signs investors should review.

General and Admin. Expense is the aggregate total of general managing and administering expenses for the company. Resverlogix's General and Admin. Expense for the three months ended in Mar. 2026 was €0.41 Mil. Its General and Admin. Expense for the trailing twelve months (TTM) ended in Mar. 2026 was €1.72 Mil.

Resverlogix General and Admin. Expense Related Terms

Resverlogix General and Admin. Expense Historical Data

* Premium members only.

The historical data trend for Resverlogix's General and Admin. Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Resverlogix General and Admin. Expense Chart

Resverlogix Annual Data

Trend

Apr16

Apr17

Apr18

Apr19

Apr20

Dec21

Dec22

Dec23

Dec24

Dec25

General and Admin. Expense

Get a 7-Day Free Trial

3.92

3.36

2.54

1.71

1.67

Resverlogix Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
General and Admin. Expense	Get a 7-Day Free Trial															0.40	0.50	0.36	0.45	0.41

39GF Score

Resverlogix Corp STU:RFS

General and Admin. Expense is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Resverlogix General and Admin. Expense Calculation

General and Admin. Expense is the aggregate total of general managing and administering expenses for the company.

General and Admin. Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €1.72 Mil.

Frequently Asked Questions Learn more about General and Admin. Expense →

What does a General and Admin. Expense of €1.72 Mil mean?

Resverlogix (STU:RFS) has a General and Admin. Expense of €1.72 Mil as of Mar. 2026. General and Admin. Expense is the aggregate total of general managing and administering expenses for the company. View historical data on Resverlogix and its competitors.

Is Resverlogix's General and Admin. Expense too high?

Resverlogix's current General and Admin. Expense is €1.72 Mil. Overall, Resverlogix has a GF Score™ of 39/100, reflecting its overall financial health beyond just this single metric.

How does Resverlogix's General and Admin. Expense compare to VRTX and REGN?

Resverlogix's General and Admin. Expense of €1.72 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good General and Admin. Expense for a Biotechnology company?

A good General and Admin. Expense depends on the Biotechnology industry context. However, General and Admin. Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high General and Admin. Expense mean?

A high General and Admin. Expense can signal that a stock is expensive relative to its fundamentals. General and Admin. Expense is the aggregate total of general managing and administering expenses for the company. View historical data on Resverlogix and its competitors. Resverlogix's current General and Admin. Expense is €1.72 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Resverlogix stock overvalued right now?

Resverlogix (STU:RFS) has a current General and Admin. Expense of €1.72 Mil. The current General and Admin. Expense is €1.72 Mil. Resverlogix's overall GF Score™ is 39/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is General and Admin. Expense calculated?

General and Admin. Expense is calculated from a company's financial statements. For Resverlogix (STU:RFS), the current General and Admin. Expense is €1.72 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Resverlogix Business Description

Industry Healthcare Biotechnology

Comparable Companies TSXV:ARCH XCNQ:LOBE TSXV:GSD TSXV:TTI TSX:MDNA TSX:BCT TSX:MBX XCNQ:MDMA TSXV:MIR NEOE:BMND VRTX REGN XBRU:UCB XBRU:ARGX XKRX:207940 ALNY RVMD ASX:CSL ONC XKRX:068270

Other Exchanges RVXCF:USA RVX:Canada

Address 4820 Richard Road SW, Suite 300, Calgary, AB, CAN, T3E 6L1

Website https://www.resverlogix.com

Resverlogix Corp clinical-stage biotechnology company. The company is developing apabetalone (RVX-208), a first-in-class, small molecule that is a selective BET (bromodomain and extra-terminal) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. Apabetalone is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. This selective inhibition of apabetalone on BD2 produces a specific set of biological effects with potentially important benefits for patients with chronic disease, including cardiovascular disease (CVD) and associated comorbidities, and COVID-19.

39GF Score

Get the complete analysis for STU:RFS

General and Admin. Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.05

Price

View STU:RFS Analysis

See General and Admin. Expense data for all stocks →